The UK stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting global economic interdependencies. In such a climate, identifying stocks trading below their estimated intrinsic value can be crucial for investors seeking opportunities amidst broader market uncertainties.
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Playtech (LSE:PTEC) | £3.916 | £7.44 | 47.3% |
| On the Beach Group (LSE:OTB) | £1.854 | £3.71 | 50% |
| Next 15 Group (AIM:NFG) | £3.17 | £6.28 | 49.5% |
| Invinity Energy Systems (AIM:IES) | £0.242 | £0.46 | 47% |
| Eurocell (LSE:ECEL) | £1.195 | £2.25 | 46.8% |
| Entain (LSE:ENT) | £5.368 | £10.04 | 46.6% |
| Convatec Group (LSE:CTEC) | £2.256 | £4.21 | 46.4% |
| Bridgepoint Group (LSE:BPT) | £3.232 | £6.04 | 46.5% |
| AstraZeneca (LSE:AZN) | £120.88 | £229.38 | 47.3% |
| Accsys Technologies (AIM:AXS) | £0.711 | £1.41 | 49.7% |
Let's review some notable picks from our screened stocks.
Overview: Burberry Group plc, along with its subsidiaries, operates in the manufacturing, retail, and wholesale of luxury goods under the Burberry brand across regions including Asia Pacific, China, Europe, the Middle East, India, Africa, and the Americas with a market cap of £3.78 billion.
Operations: The company's revenue is primarily derived from Retail/Wholesale at £2.36 billion and Licensing at £62 million.
Estimated Discount To Fair Value: 32.2%
Burberry Group is trading at £10.57, significantly below its estimated future cash flow value of £15.59, indicating it may be undervalued based on cash flows. The company's earnings are forecast to grow 34.9% annually over the next three years, outpacing the UK market's growth rate of 11.6%. Despite a slower revenue growth forecast of 5.6%, Burberry's strong profit growth prospects and recent strategic board appointments bolster its potential for future performance improvement.
Overview: Croda International Plc operates in the consumer care, life science, and industrial specialty sectors across Europe, the Middle East, Africa, North America, Asia, and Latin America with a market capitalization of approximately £4.67 billion.
Operations: The company's revenue segments are comprised of Consumer Care at £1.00 billion, Life Sciences at £528.50 million, and Industrial Specialties at £191 million.
Estimated Discount To Fair Value: 11.9%
Croda International is trading at £33.35, slightly below its estimated future cash flow value of £37.85, suggesting a potential undervaluation. Earnings are forecast to grow significantly at 22.9% annually, outpacing the UK market's growth rate of 11.6%. Recent half-year results showed increased sales (£880.5 million) and net income (£78.7 million). However, profit margins have declined from last year, and the dividend coverage remains weak despite a declared interim dividend of 48 pence per share for 2026.
Overview: Mondi plc, along with its subsidiaries, operates in the manufacture and sale of packaging and paper solutions across various regions including Africa, Western Europe, Emerging Europe, North America, South America, Asia, and Australia; it has a market cap of approximately £3.78 billion.
Operations: The company's revenue is primarily derived from Flexible Packaging, which accounts for €3.92 billion, and Corrugated Packaging, contributing €3.86 billion.
Estimated Discount To Fair Value: 19.4%
Mondi is trading at £8.58, below its estimated future cash flow value of £10.65, indicating potential undervaluation. The company faces challenges with a recent net loss of €255 million and reduced interim dividend to 9.42 euro cents per share for 2026 compared to last year. Despite high debt levels, Mondi is forecasted to achieve profitability within three years with earnings growth expected at 83.45% annually, surpassing the UK market's average growth rate.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com